Chemical Compound

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-(5Z)-5-heptenoic acid 1-methylethyl ester; [1R-[1alpha(Z),2beta(1E,3R*),3alpha,5alpha]]-7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-Heptenoic acid 1-methylethyl ester; AL 6221; Travaprost; Travatan; Travatanz; Travoprost

CAS Registry Number 157283-68-6
7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-(5Z)-5-heptenoic acid 1-methylethyl ester; [1R-[1alpha(Z),2beta(1E,3R*),3alpha,5alpha]]-7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-Heptenoic acid 1-methylethyl ester; AL 6221; Travaprost; Travatan; Travatanz; Travoprost 结构式
Primary record

7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-(5Z)-5-heptenoic acid 1-methylethyl ester; [1R-[1alpha(Z),2beta(1E,3R*),3alpha,5alpha]]-7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-Heptenoic acid 1-methylethyl ester; AL 6221; Travaprost; Travatan; Travatanz; Travoprost

库存
9,107 克
纯度
99.7 %
CAS
157283-68-6

化合物标识与属性

CAS
157283-68-6
PubChem CID
5282226
SMILES
CC(C)OC(=O)CCC/C=C\C[C@H]1[C@H](C[C@H]([C@@H]1/C=C/[C@H](COC2=CC=CC(=C2)C(F)(F)F)O)O)O
Canonical SMILES
CC(C)OC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)COc2cccc(C(F)(F)F)c2)[C@H](O)C[C@@H]1O

名称与同义词

  • Travoprost
  • Travatan
  • Travatan Z
  • Izba
  • Travaprost
  • Travatanz
  • 157283-68-6
  • travoprostum
  • Otx-tp
  • Travatan Alcon
  • Travoprost [USAN]
  • Trovoprost
  • Z, Travatan
  • Travatan (TN)
  • IDOSE TR
  • 15S-Travoprost
  • Travoprost in bulk
  • AL-6221
  • Travatan Z (TN)
  • Travatan, Travoprost
  • Travoprost Ophthalmic
  • Travoprostintermediates
  • Travoprost (Standard)
  • TV-BK (Travoprost)
  • Travoprost Intracameral
  • AC1NQZOS
  • RefChem:56256
  • TRAVOPROST [MI]
  • C26H35F3O6
  • AL6221
  • TRAVOPROST [INN]
  • TRAVOPROST [JAN]
  • UNII-WJ68R08KX9
  • WJ68R08KX9
  • Travoprost (Isomer Free)
  • TRAVOPROST [VANDF]
  • D09CZA
  • Fluprostenol isopropyl ester
  • TRAVOPROST [MART.]
  • CHEBI:746859
  • MKPLKVHSHYCHOC-AHTXBMBWSA-N
  • TRAVOPROST [USP-RS]
  • TRAVOPROST [WHO-DD]
  • SCHEMBL93818
  • Travoprost (JAN/USP/INN)
  • Travoprost (JAN/USAN/INN)
  • TRAVOPROST [EMA EPAR]
  • Travoprost Ophthalmic Solution
  • (+)-Fluprostenol isopropyl ester
  • DTXSID80896948
  • MFCD03411995
  • DUOTRAV COMPONENT TRAVOPROST
  • GTPL7102
  • orb1301441
  • orb3025009
  • Travoprost [USAN:USP:INN:BAN]
  • CHEMBL1200799
  • NSC-760366
  • SCHEMBL29830793
  • TRAVOPROST [ORANGE BOOK]
  • AL 6221
  • HY-B0584R
  • S01EE04
  • DTXCID401326382
  • GLXC-23326
  • TRAVOPROST [USP MONOGRAPH]
  • EX-A1772
  • HY-B0584
  • MSK15028
  • ZINC4474682
  • BDBM50248302
  • EBC-27241
  • s3738
  • AKOS024458039
  • C26-H35-F3-O6
  • AC-6103
  • ACN-040046
  • AM84515
  • CCG-269692
  • CID5282226
  • CS-2773
  • DB00287
  • FT28371
  • NSC 760366
  • RP17770
  • CID:5282226
  • NCGC00346741-02
  • AN-10392
  • BS-15509
  • FT104213
  • M978
  • SC-50922
  • SY028641
  • Travoprost Ophthalmic Solution, 0.004%
  • SID:283537565
  • AB2000145
  • LS-173521
  • NS00007104
  • Z6131
  • (Z)-isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
  • Fluprostenol isopropyl ester;AL6221;Flu-Ipr
  • J1.152.432J
  • Travoprost Ophthalmic Solution USP, 0.004%
  • A12104
  • D01964
  • SBI-0654083.0001
  • propan-2-yl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
  • 283T686
  • A809828
  • C438103
  • EN300-21831206
  • SR-01000942266
  • SR-01000946860
  • (((1R)-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester
  • Q2193376
  • SR-01000942266-1
  • SR-01000946860-1
  • BRD-K23976833-001-01-0
  • Fluprostenol isopropyl ester, >=98%, ethanol solution
  • (1R-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-7-(3,5-Dihydroxy-2-(3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-5-heptenoic acid, 1-methylethyl ester
  • 5-Heptenoic acid, 7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-, 1-methylethyl ester, (5Z)-
  • D000069557
  • propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl]cyclopentyl]hept-5-enoate
  • Travoprost Ophthalmic Solution USP, 0.004% Travoprost
  • B0084-059917
  • (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3R)-3-hydroxy-4-((alpha,alpha,alpha-trifluoro-m-isopropyl-tolyl)oxy)-1-butenyl)cyclopentyl)-5-heptenoate
  • 5-Heptenoic acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl ester, (5Z)-
  • 5-Heptenoic acid, 7-(3,5-dihydroxy-2-(3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl ester, (1R-(1alpha(Z),2beta(1E,3R*),3alpha,5alpha))-
  • isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[(alpha,alpha,alpha-trifluoro-m-tolyl)oxy]-1-butenyl}cyclopentyl)-5-heptenoate
  • propan-2-yl (5Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-{(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-en-1-yl}cyclopentyl]hept-5-enoate
  • 5-Heptenoic acid,7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-,1-methylethyl ester,(5Z)
  • isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
  • isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]but-1-enyl]cyclopentyl]hept-5-enoate
  • (+)-16-[3-(trifluoromethyl)phenoxy]-17,18,19,20-tetranorprostaglandin F2alpha isopropyl ester
  • (1R-(1.ALPHA.(Z),2.BETA.(1E,3R*),3.ALPHA.,5.ALPHA.))-7-(3,5-DIHYDROXY-2-(3-HYDROXY-4-(3-(TRIFLUOROMETHYL)PHENOXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOIC ACID, 1-METHYLETHYL ESTER
  • (5Z)-7-[(1R)-2beta-[(1E,3R)-3-Hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]-3alpha,5alpha-dihydroxycyclopentan-1alpha-yl]-5-heptenoic acid isopropyl ester
  • (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-5-heptenoic acid 1-methyethyl ester
  • (5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-heptenoic acid isopropyl ester
  • (Z)-isopropyl 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl) phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
  • (Z)-isopropyl7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((R,E)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate
  • 157283-72-2
  • 208111-98-2
  • 340181-93-3
  • 4-(3-hydroxy-3-methyloct-1-enyl)-5-(7-phosphanylidene-7-propan-2-yloxyhept-2-enyl)cyclopentane-1,3-diol
  • 5-Heptenoic Acid, 7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)-1-butenyl)cyclopentyl)-, 1-methylethyl Ester,(5Z)-
  • 7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3R)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-(5Z)-5-heptenoic acid 1-methylethyl ester; [1R-[1alpha(Z),2beta(1E,3R*),3alpha,5alpha]]-7-[3,5-dihydroxy-2-[3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-butenyl]cyclopentyl]-5-Heptenoic acid 1-methylethyl ester; AL 6221; Travaprost; Travatan; Travatanz; Travoprost
  • ISOPROPYL (Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3R)-3-HYDROXY-4-((.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-M-TOLYL)OXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOATE
  • ISOPROPYL (Z)-7-((1R,2R,3R,5S)-3,5-DIHYDROXY-2-((1E,3R)-3-HYDROXY-4-((alpha,alpha,alpha-TRIFLUORO-M-TOLYL)OXY)-1-BUTENYL)CYCLOPENTYL)-5-HEPTENOATE
  • Isopropyl (Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((3R,E)-3-hydroxy-4-(3-(trifluoromethyl)-phenoxy)-but-1-enyl)-cyclopentyl)-hept-5-enoate
  • Isopropyl (Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(R,E)-3-hydroxy-4-[3-(trifluoromethyl)phenoxy]-1-buten-1-yl]cyclopentyl]-5-heptenoate
  • propan-2-yl (5Z)-7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3R)-3-hydroxy-4-(3-(trifluoromethyl)phenoxy)but-1-en-1-yl)cyclopentyl)hept-5-enoate